“Just right” combinations of adjuvants with nanoscale carriers activate aged dendritic cells without overt inflammation
Abstract Background The loss in age-related immunological markers, known as immunosenescence, is caused by a combination of factors, one of which is inflammaging. Inflammaging is associated with the continuous basal generation of proinflammatory cytokines. Studies have demonstrated that inflammaging...
Main Authors: | Ananya Ananya, Kaitlyn G. Holden, Zhiling Gu, Dan Nettleton, Surya K. Mallapragada, Michael J. Wannemuehler, Marian L. Kohut, Balaji Narasimhan |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2023-03-01
|
Series: | Immunity & Ageing |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12979-023-00332-0 |
Similar Items
-
How Can We Improve Vaccination Response in Old People? Part I: Targeting Immunosenescence of Innate Immunity Cells
by: Anna Aiello, et al.
Published: (2022-08-01) -
Novel nanoadjuvants balance immune activation with modest inflammation: implications for older adult vaccines
by: Kathleen A. Ross, et al.
Published: (2023-06-01) -
Dendritic Cells and Cancer Immunotherapy: The Adjuvant Effect
by: Sara Nava, et al.
Published: (2021-11-01) -
Nanoscale Sub-Compartmentalization of the Dendritic Spine Compartment
by: Ana Sofía Vallés, et al.
Published: (2021-11-01) -
COVID-19: Gender and Outcomes
by: Alfonso Ilardi
Published: (2022-04-01)